SIGA

SIGA Technologies Inc.

Price

$3.03

return (12m)

-61.64%

p/e

-78.14

p/bv

1.32

DIVIDEND YIELD

19.77%

SIGA price

SIGA Technologies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SIGA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

4.30%

3 months

-30.02%

1 year

-61.64%

2 years

-52.17%

5 years

-29.46%

10 years

85.22%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SIGA

Valuation

P/E

-78.14

Sector 0.30

Industry 2.11

P/BV

1.32

Sector 1.85

Industry 2.24

P/Revenue (PSR)

4.06

Sector 1.55

Industry 1.78

EV/EBITDA

7.13

Sector -47.98

Industry -1.11

EV/EBIT

7.20

Sector -34.76

Industry -8.71

P/EBITDA

-20.65

Sector -37.73

Industry -54.67

P/EBIT

-19.55

Sector -43.70

Industry -52.63

P/Total Assets

1.24

Sector 0.88

Industry 1.00

P/Net Current Assets

1.36

Sector -27.97

Industry -10.95

P/Working Capital

1.34

Sector -3.40

Industry 1.40

EPS

-0.04

Sector -0.77

Industry -0.69

BVPS

2.30

Sector 4.04

Industry 4.67

Efficiency

Gross Margin

54.35%

Sector 48.57%

Industry 49.58%

EBITDA Margin

34.29%

Sector -310.04%

Industry -56.64%

EBIT Margin

33.92%

Sector -179.86%

Industry -55.50%

Operating Margin

-20.76%

Sector -21.72%

Industry -27.73%

Net Profit Margins

-5.19%

Sector -26.17%

Industry -31.12%

Asset Turnover

0.23

Sector 0.13

Industry 0.15

Profitability

ROE

-1.69%

Sector -27.31%

Industry -25.93%

ROA

-1.59%

Sector -25.75%

Industry -26.03%

ROIC

127.60%

Sector -590.50%

Industry -95.34%

Dividends

Dividend yield

19.77%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

21.72

Sector 1.92

Industry 2.01

Net Debt / EBITDA

-8.36

Sector -23.56

Industry -2.23

Net Debt / EBIT

-8.46

Sector -3.30

Industry -1.54

Net Debt / Equity

-0.71

Sector -0.69

Industry -0.28

Gross Debt / Equity

0.00

Sector 0.09

Industry -0.81

Equity/Assets

0.94

Sector 0.45

Industry 0.46

Liabilities/Assets

0.06

Sector 0.49

Industry 0.52

Growth

5Y Revenue CAGR

-16.69%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SIGA

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SIGA SIGA Technologies Inc.	$3.03	-61.64%	19.77%	-78.14	1.32	-1.69%	-5.19%
LLY Eli Lilly and Compay	$1,115.70	48.63%	0.59%	37.57	29.62	78.84%	33.53%
SNY Sanofi	$42.77	-5.47%	4.16%	3.98	0.73	18.43%	14.25%
GSK GlaxoSmithKline PLC	$48.13	23.26%	3.68%	14.78	4.17	28.24%	14.54%
CRMD CorMedix Inc.	$7.83	-39.53%	0.00%	3.35	1.36	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.78	-15.25%	0.00%	13.15	1.34	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$11.90	-18.24%	0.70%	27.08	2.44	9.03%	10.14%
ENLV Enlivex Therapeutics Ltd.	$0.96	-94.02%	0.00%	0.01	0.01	63.85%	0.00%
ISRG Intuitive Surgical Inc.	$369.15	-17.91%	0.00%	41.36	7.14	17.26%	28.62%
NVS Novartis AG	$137.16	12.65%	2.25%	20.58	6.25	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$609.82	27.74%	0.29%	32.54	4.31	13.25%	15.07%
ABT Abbott Laboratories	$101.95	-22.02%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$90.96	0.64%	3.17%	21.85	2.26	10.35%	14.02%
BSX Boston Scientific Corp.	$42.98	-58.15%	0.00%	17.35	2.55	14.73%	17.49%
TMDX TransMedics Group Inc.	$82.18	-28.27%	0.00%	18.39	5.39	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$504.70	-21.28%	0.00%	34.83	24.62	70.67%	25.03%
RMD ResMed Inc.	$218.27	-18.17%	1.11%	20.57	4.76	23.13%	26.94%
HCA HCA Healthcare Inc.	$426.94	6.08%	0.70%	11.97	-29.30	-244.72%	10.07%
COHR Coherent Inc.	$305.37	196.50%	0.00%	74.57	5.29	7.09%	11.19%
DHR Danaher Corporation	$200.14	6.09%	0.71%	35.51	2.70	7.61%	15.95%
SYK Stryker Corp.	$275.56	-27.17%	1.29%	27.75	4.31	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SIGA Historical Dividends

current DY: 19.77%

5-year average DY: 10.83%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	04/06/2026	04/23/2026	0.60000000
Dividends	04/28/2025	05/15/2025	0.60000000
Dividends	03/22/2024	04/11/2024	0.60000000
Dividends	05/12/2023	06/01/2023	0.45000000
Dividends	05/13/2022	06/02/2022	0.45000000

ABOUT SIGA Technologies

SIGA Technologies Inc.

Average Investor10 user rating

4.0 (7 people)

United States

31 years

Founded: 1995

1997

Time since IPO - 29 years

42

Employees

SIGA Technologies Inc. (United States) is listed on the Nasdaq and has a market capitalization of $217.77 million, with shareholders equity totaling $165.29 million.

The company employs approximately 42 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, SIGA Technologies Inc. reported $53.66 million in revenue, generating net income of $-2.79 million.

Key financial metrics include a P/E ratio of -78.14, a price-to-book (P/B) ratio of 1.32, and a trailing twelve-month dividend yield of 19.77%.

The company trades under the ticker SIGA.

Market cap

$217.77 million

Net worth

$165.29 million

$165,291,000.00

Assets

$175.74 million

$175,737,000.00

Total Shares Outstanding

71.75 million

71,752,000

Average Daily Trading Volume

$731.08 Thousand

$731,080.74

Sector

Health

Industry

Pharmaceutical Products

SIGA

SIGA revenue and profits

Financial Results SIGA

DRAG THE FRAME TO SEE MORE DATA

SIGA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$94.66 30,24% (12M)

P/E

-0.84

2.82%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$280.76 --4,70% (12M)

P/E

10.69

2.22%

ROE

16.04%

P/BV

1.72

CNC - Centene

$66.42 99,70% (12M)

P/E

-6.30

0.00%

ROE

-22.56%

P/BV

1.42

HUM - Humana

$409.80 50,71% (12M)

P/E

37.65

0.87%

ROE

6.72%

P/BV

2.53

SNY - Sanofi

$42.77 --5,47% (12M)

P/E

3.98

4.16%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,115.70 48,63% (12M)

P/E

37.57

0.59%

ROE

78.84%

P/BV

29.62

HCA - HCA Healthcare

$426.94 6,08% (12M)

P/E

11.97

0.70%

ROE

-244.72%

P/BV

-29.30

NVS - Novartis

$137.16 12,65% (12M)

P/E

20.58

2.25%

ROE

30.39%

P/BV

6.25